Open Access Highly Accessed Research article

MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1

Jing Liu1, Kai-Hua Lu23, Zhi-Li Liu1, Ming Sun4, Wei De4 and Zhao-Xia Wang1*

Author Affiliations

1 Department of Oncology, The Second Affiliated Hospital of Nanjing Medical University, 121 Jiangjiayuan Road, Nanjing, Jiangsu, 210011, Peoples Republic of China

2 Immunology and Reproductive Biology Lab of Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, 210093, Peoples Republic of China

3 Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, Peoples Republic of China

4 Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, Jiangsu, 210029, Peoples Republic of China

For all author emails, please log on.

BMC Cancer 2012, 12:519  doi:10.1186/1471-2407-12-519

Published: 14 November 2012

Additional files

Additional file 1:

Table S1. Association between miR-100 expression and clinicopathological features of NSCLC patients. (DOC 45 kb)

Format: DOC Size: 45KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data